Scarica l'app Stockscreener
0.00
100.00%
-0.6063
Precedente Chiudi:
$0.6063
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$20.66M
Reddito:
$247.99M
Utile/perdita netta:
$-521.97M
Rapporto P/E:
0.00
EPS:
-1.11
Flusso di cassa netto:
$-194.28M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$12.76
23 Andme Holding Co Stock (ME) Company Profile
Nome
23 Andme Holding Co
Settore
Industria
Telefono
(650) 938-6300
Indirizzo
223 N. MATHILDA AVE., SUNNYVALE
Confronta ME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 20.66M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
424.24 | 159.25B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.14 | 132.37B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
437.44 | 32.95B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
106.28 | 28.58B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
150.28 | 24.90B | 15.41B | 1.37B | 2.11B | 7.50 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-09-22 | Iniziato | Cowen | Outperform |
| 2021-11-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-07-12 | Iniziato | Citigroup | Buy |
23 Andme Holding Co Borsa (ME) Ultime notizie
23andMe Goes Bankrupt as Only 550,000 Subscribe to Gene Testing - MSN
23andMe Has Received 'Significant Interest' In Ch. 11 Auction - Law360
23andMe bankruptcy sale may need national security review - Reuters
23andMe Ch. 11 Sale Sparks DNA Privacy Oversight Battle - Law360
23andMe Provides Update Regarding Court-Supervised Sale Process - The Manila Times
US says 23andMe deal could prompt national security review - The Edge Malaysia
US Says 23andMe Deal Could Prompt National Security Review - Bloomberg
Data Breach, Market Challenges Led 23andMe To Ch. 11 - Law360
Lawmakers launch investigation into 23andMe after bankruptcy - Yahoo News UK
23andMe Faces House Panel Query Over Customer Data - marketscreener.com
Bankrupt 23andMe Needs Security Examiner for Data, 27 States Say - Bloomberg Law News
US House committee seeks testimony from 23andMe co-founder after bankruptcy - Reuters
Competing plans to handle 23andMe genetic data could come to a head in bankruptcy court - The Business Journals
Under The Radar: Bankruptcy News You May Have Missed - Law360
23andMe Asks For Independent Customer Data Rep In Ch. 11 - Law360
Kelley Drye Selected as Counsel to the Official Committee of Unsecured Creditors of 23andMe - Kelley Drye & Warren LLP
Bankrupt 23andMe Seeks Independent Rep to Ease DNA Sale Fears - Bloomberg Law News
What Happens to Your Personal Data When a Company Folds? - MSN
23andMe filed for bankruptcy. What’s going to happen to your DNA data? - Fort Worth Star-Telegram
Luke O’Neill: Why genetic testing company 23andMe is bankrupt - Newstalk
Charles Schwab Investment Management Inc. Sells 254,034 Shares of 23andMe Holding Co. (NASDAQ:ME) - Defense World
Fortune Tech: All-out panic - Fortune
FTC eyeing 23andme’s disposition of genomic data - BioWorld MedTech
Decoding 23andMe’s downfall - Chemistry World
FTC wants to ensure 23andMe customers personal data protected - Seeking Alpha
FTC concerned about privacy protections in 23andMe bankruptcy - Reuters
FTC Raises Concerns Over Sale of Data in 23 and Me Bankruptcy - Bloomberg Law News
FTC Chief Stresses Importance of 23andMe Privacy Protections in Bankruptcy - MarketScreener
Lifeline For 23andMe? Stock Jumps After Court Greenlights Bankruptcy Asset Sale, Retail Weighs Possible Rescue - Asianet Newsable
23andMe’s failure shows how risky it can be to invest in a SPAC - Yahoo Finance
Maryland AG Warns Consumers After 23andMe Bankruptcy - The Southern Maryland Chronicle
23andMe wants to sell its most valuable asset. Will your private DNA data be safe? - MSN
Anne Wojcicki, the floundering 23andMe’s eternal optimist - Financial Times
23andMe'S Major Market Move Marks Strategic Shift - Finimize
Meet The Attys Helping 23AndMe Through Ch. 11 - Law360
23andMe stock rises as judge clears DNA data sale (ME:NASDAQ) - Seeking Alpha
Bankrupt 23andMe’s DNA Data Gets Sale Nod as Concerns Linger - Claims Journal
Stock Movers: GM, 23andMe, Gamestop - Bloomberg.com
Bankrupt 23andMe’s DNA data gets sale nod as concerns linger - The Mercury News
23andMe Holding Co. (ME) Halted on Volatility, Up 117% - StreetInsider
Bankrupt 23andMe’s DNA Data Gets Nod for Sale as Concerns Linger - Bloomberg
Genetics group 23andMe files for US bankruptcy as co-founder quits - MSN
23andMe Says Consumer Privacy Policies Remain in Place - Marketscreener.com
DNA Tester 23andMe Files Bankruptcy to Sell Firm, CEO Quits - MSN
With 23andMe filing for bankruptcy, what happens to consumers’ genetic data? - The Conversation
23andMe Says Ch. 11 Privacy Ombudsman Not Required - Law360
23andMe Confirms All Potential Buyers Must Agree to Comply With Privacy Policy and Applicable Law - GlobeNewswire
23Andme Holding Says Receives Court Approval For First Day Motions In Chapter 11 Case - MarketScreener
23andMe's $35M Bankruptcy Deal Keeps Customer DNA Data Protected - Stock Titan
23 Andme Holding Co Azioni (ME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):